ASTRAZENECA CAMCAR, S.A., a division of AstraZeneca focused in Central American and Caribbean countries, has partnered with Cancer Genetics Inc. to provide biomarker-based diagnostic testing for cancer.
“I don’t think any good cancer center director would be worth their weight in salt if they weren’t worried about something at night,” said Mark Evers, director of University of Kentucky Markey Cancer Center.
